Ticker Scorecard - XENE Basics Company: Xenon Pharmaceuticals Inc. IPO Date: November 5, 2014 Sector: Healthcare Industry: Biotech Market Cap: $3.03B Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 2.52% Avg Daily Range (30 D): $0.45 | 1.15% Avg Daily Range (90 D): $0.64 | 1.57% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .34M Avg Daily Volume (90 D): .32M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 1,920 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $1.52M Avg Inst. Trade (90 D): $1.46M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.23M Avg Closing Trade (30 D): $1.52M Avg Closing Trade (90 D): $1.42M Avg Closing Volume: 34.27K     News Feb 20, 2025 @ 6:00 PM Epilepsy Market Assessment in the 7MM by 2034 ââ‚... Source: Delveinsight Jul 2, 2024 @ 1:22 PM Longboard (LBPH) Up 14% as Epilepsy Drug Gets Brea... Source: Zacks Equity Research May 28, 2024 @ 12:30 PM Xenon Pharmaceuticals Presents Data from Phase 2 X... Source: Xenon Pharmaceuticals Inc. May 10, 2024 @ 12:17 PM Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline ... Source: Zacks Equity Research May 9, 2024 @ 8:01 PM Xenon Pharmaceuticals Reports First Quarter 2024 F... Source: Xenon Pharmaceuticals Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.81 $-.81 $-.75 Diluted EPS $-2.81 $-.81 $-.75 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -213.39M $ -62.79M $ -57.92M Operating Income / Loss $ -255.52M $ -73.68M $ -69.1M Cost of Revenue $ $ $ Net Cash Flow $ 49.58M $ -.05M $ .2M PE Ratio